slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 80,191-80,220
Pages 3,986
Rows per page 30
Component
80,191-80,220 of 119,566
12
The slide highlights both financial traction (milestones) and clinical progress (Phase 1 trials).Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
01
The year '2022' is stylized with biological imagery inside the digits.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
04
Standard pharmaceutical regulatory disclosure slide.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
05
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
07
The slide uses a central human body diagram surrounded by cell types and lists of functions and diseases to illustrate the systemic importance of the immune system.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Problem StatementLoop · Logic Chain1 hit
09
Includes a list of key metrics and a bottom banner highlighting broader societal impact.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Problem StatementLoop · Logic Chain1 hit
11
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Solution OverviewLoop · Logic Chain1 hit
13
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Solution OverviewLoop · Logic Chain1 hit
16
The slide maps biological interactions (APC, T cell, Tumor cells, etc.) to five specific therapeutic modalities (mRNA vaccines, cell therapies, immunomodulators, etc.).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Solution OverviewLoop · Logic Chain1 hit
18
The slide uses a process diagram to illustrate the evolution of cancer cells from healthy cells.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Solution OverviewLoop · Logic Chain1 hit
22
The slide highlights step 2 (Mapping of mutations) and provides a visual representation of DNA sequencing comparing normal and cancer cells.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
23
The slide highlights the transition from automated computational prediction to human expert verification.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
30
The slide uses a structured table format to map technical mRNA variations to clinical outcomes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
The slide uses a combination of microscopy images and a line chart to demonstrate efficacy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
32
The slide uses a combination of molecular biology diagrams and experimental data (flow cytometry and VNT-titer scatter plots) to support the efficacy of taRNA.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
34
Includes schematic of lipid bilayer structure, RNA-lipoplex screening process, and bioluminescence imaging data.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
35
Includes chemical structure of PSAR-LNP components and a line chart comparing in vivo expression profiles.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
39
The slide uses biological diagrams to illustrate the process of T-cell recognition and tumor cell interaction, alongside a list of key criteria for neoantigen prediction.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
44
The slide shows structural models of spike proteins (Wuhan, Beta, Omicron) alongside scatter plots correlating epitope alteration/semantic change/immune escape scores with pVNT50 reduction and ACE2 binding affinity.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
49
The slide uses a map-based visualization to communicate operational scale and geographic reach.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
51
The slide highlights the rapid conversion of a Novartis facility into a high-capacity mRNA vaccine production site.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
55
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
62
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
63
FIH stands for first-in-human.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
66
The slide uses a timeline-like progression of vaccine development stages.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
76
Includes a 3D structural model of the RBD with color-coded mutation sites and a corresponding table of amino acid changes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
78
The chart uses a log scale for the y-axis (pVN50 titer).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
83
The slide uses a map-based visual to illustrate a hub-and-spoke network model for vaccine manufacturing.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
85
Includes citations at the bottom.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
86
The slide uses a structural biology diagram to explain the modularity of endolysins.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit